Results 131 to 140 of about 971 (198)

Increased intracranial pressure in NF2‑related schwannomatosis: an underestimated danger with serious consequences. [PDF]

J Neurooncol
Keraudy A, Vincent C, Risoud M, Monfilliette A, Hanafi R, Peyre M, Reyns N, Kalamarides M, Aboukais R.   +8 more
europepmc   +1 more source

The Neurofibromatoses

, 2019
Bruce R. Korf, Amy Theos, Kevin P. Boyd
core   +1 more source

Wide-field two-photon random illumination microscopy (2P-RIM). [PDF]

Sci Adv
Benachir A, Li X, Fantuzzi EM, Giroussens G, Mangeat T, Vernuccio F, Rigneault H, Sentenac A, Heuke S.   +8 more
europepmc   +1 more source

Neurofibromatoses in Clinical Practice

, 2011
Susan M. Huson, Rosalie E. Ferner, D. Gareth R. Evans   +2 more
core   +1 more source

Dieter Kaufmann, editor: Neurofibromatoses

, 2008

core   +1 more source

Neurofibromatoses : quel risque épileptique ?

, 2011
A. Drouet
core   +1 more source

Neurofibromatoses: A Clinical Overview

, 2013

core   +1 more source

Determinants of the quality of life of patients with NF2-related schwannomatosis and validation of the Dutch NFTI-QOL questionnaire. [PDF]

Fam Cancer
Tops AL, Goemans D, Aten E, Schopman JE, Koot RW, Gelderblom H, Jansen JC, Hensen EF.   +7 more
europepmc   +1 more source

[⁸⁹Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial. [PDF]

BMJ Open
Douwes JPJ, Tops AL, Dibbets-Schneider P, Verbist BM, Fuentealba Bassaletti CA, Jansen JC, Koetsier KS, van Dam VS, Koot RW, van Velden FHP, Pool M, Vugts D, Schopman JE, Goeman JJ, De Geus-Oei LF, Hensen EF, Gelderblom H.   +16 more
europepmc   +1 more source

Psychological Impact of the Neurofibromatoses

, 2011
Rosalie E. Ferner
core   +1 more source